Cargando…
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease
Hepatocellular carcinoma (HCC) is the most common primary liver cancer in patients with liver cirrhosis of various etiologies. In recent years, there has been an advance in the knowledge of molecular mechanisms and a better staging definition of patients which has allowed the development of new ther...
Autores principales: | Jose, Anju, Bavetta, Maria Grazia, Martinelli, Erika, Bronte, Fabrizio, Giunta, Emilio Francesco, Manu, Kanjoormana Aryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825221/ https://www.ncbi.nlm.nih.gov/pubmed/36624801 http://dx.doi.org/10.1155/2022/3817724 |
Ejemplares similares
-
Editorial: Reviews in gastrointestinal cancers
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2023) -
Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022) -
Editorial: The role of non-coding RNAs in gastrointestinal cancer
por: Kumar, Divya P., et al.
Publicado: (2022) -
Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
por: Chai, Tin Fan, et al.
Publicado: (2020) -
What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
por: Bronte, Enrico, et al.
Publicado: (2015)